SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires quarterly results have drawn attention, with weaker insurance performance offset by a sharp increase in share repurchases. Traders are debating whether buybacks and the companys large cash reserve support confidence in Greg Abels capital allocation, or whether softer operations and limited cash deployment weigh on the outlook.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,078,194,480.417637 in circulation. The last known price of Algorand is 0.09693394 USD and is up 3.39 over the last 24 hours. It is currently trading on 586 active market(s) with $57,858,585.39 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGO is drawing attention as traders debate whether it can recover the 10-cent area after a prolonged decline; bearish posts point to weak momentum and overhead resistance, while bulls argue the token is near a base and cite Algorands leadership change and technology as reasons for optimism. No clear consensus has emerged, and much of the discussion is speculative.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

A sharp reversal in financials after recent highs, alongside put-heavy options activity, has traders debating whether the weakness is routine profit-taking or a warning of further sector downside. Some also cite concerns about banks exposure to AI-related lending and broader credit risks, while others view the pullback as temporary.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is drawing attention amid a sharp technology-sector pullback and worries that debt-funded AI and data-center spending may not deliver adequate returns; the funds concentration in major tech and chip stocks amplifies those concerns. Traders are watching heavy put activityuncertain whether it reflects hedging or bearish betswhile debating whether oversold conditions could support a bounce or whether further weakness lies ahead.

NextEra Energy, Inc. engages in the provision of renewable energy. It operates through the Florida Power and Light Company (FPL) and NextEra Energy Resources and NEET (NEER). The FPL segment involves the generation, transmission, distribution, and sale of electric energy in Florida. The NEER segment produces electricity from clean and renewable sources, including wind and solar. The company was founded on December 28, 1925 and is headquartered in Juno Beach, FL.

NextEra Energy Inc

NextEras potential to benefit from AI-driven data-center power demand is a recurring focus, alongside concerns that grid spending may get ahead of confirmed customer demand. Traders are divided between viewing the buildout as a growth opportunity and questioning regulatory approval, project execution, and who ultimately bears the costs.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,366,684,616.305855 in circulation. The last known price of Stellar is 0.15346137 USD and is down -1.11 over the last 24 hours. It is currently trading on 848 active market(s) with $109,670,947.94 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLM is being discussed amid persistent price weakness and a broader crypto-market selloff, with bearish traders warning of further declines while others are buying the dip. Bullish holders point to Stellars tokenization and institutional-payment activity, but some argue those developments may not lift XLMs price without stronger token demand.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

A broad-market pullback and heightened volatility have put VOO in focus, with traders debating whether tech-led weakness and concerns about inflation, interest rates, and geopolitical risks signal a deeper downturn or a dip-buying opportunity. Many are adding to long-term positions, while others warn that the decline could continue.

Barclays Bank Plc engages in providing commercial banking services. It offers personal, premier, business, and corporate banking products and services to its customers. Its services include current accounts, savings, investments, mortgages, loans, insurance, credit cards, and online banking. The company was founded on October 4, 1971 and is headquartered in London, the United Kingdom.

Barclays Bank PLC - iPathÂ® Series B S&P 500Â® VIX Short-Term FuturesTM ETN

iPath S&P 500 VIX Short-Term Futures ETN

VXX is drawing attention as traders seek or trade short-term volatility exposure amid equity-market swings and geopolitical concerns, especially tensions involving Iran and the Strait of Hormuz. Some are buying calls or holding VXX as protection against another volatility spike, while others expect pops to fade and favor shorting because futures contango can erode the product over time.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Attention centers on Revolution Medicines upcoming Q3 earnings and whether the first full quarter of Rasonque sales shows a sustained launch ramp, with traders focused on new patient starts. The discussion also weighs the drugs pancreatic-cancer survival results and commercial potential against concerns about the companys rich valuation, subgroup efficacy, and emerging RAS-inhibitor competition.

Vanguard World Fund - Vanguard Information Technology ETF

Vanguard Information Technology ETF

Weakness in technology and AI-related stocks has focused attention on VGT, with traders split between buying the dip and waiting for a deeper correction amid broader market and rate uncertainty. Many describe adding or holding for the long term, while others remain cautious about further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?

Profound Medical (PROF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Profound Medical (PROF) Q2 Earnings Surpass Estimates

Profound Medical (PROF) delivered earnings and revenue surprises of +218.18% and -55.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Are Medical Stocks Lagging  Perspective Therapeutics, Inc. (CATX) This Year?

Here is how Perspective Therapeutics (CATX) and Bristol Myers Squibb (BMY) have performed compared to their sector so far this year.

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Medical sector earnings are off to a strong start, and four biotech companies are positioned to potentially beat estimates in upcoming quarterly results.

Perspective Therapeutics (CATX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Perspective Therapeutics (CATX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Is Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year?

Here is how Perspective Therapeutics (CATX) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.

4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates

4D Molecular Therapeutics (FDMT) delivered earnings and revenue surprises of -4.12% and -19.07%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

New Treatment Modalities Are Reaching Cancers That Resisted Everything Else

New Treatment Modalities Are Reaching Cancers That Resisted Everything Else New Treatment Modalities Are Reaching Cancers That Resisted Everything Else PR Newswire VANCOUVER, BC, Feb. 17, 2026 Issued...

$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors

$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors $668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors PR Newswire VANCOUVER, BC, Jan. 30, 2026 Issued on behalf of...

Stevanato Group (STVN) Q3 Earnings and Revenues Surpass Estimates

Stevanato (STVN) delivered earnings and revenue surprises of +14.29% and +5.54%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded by Michael K. Schultz in 1983 and is headquartered in Seattle, WA.

Perspective Therapeutics Inc

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.84
Prev Close	$0.7884
Open	$0.7874
Dividend Yield	0.00%
50-Day Moving Average	$2.34
Beta	1.49
Avg. Volume	2.75M
PE Ratio	-0.63

52-Week High	$6.16
52-Week Low	$0.7814
Market Capitalization	$95.89M
EPS (Annual)	-$1.40
Price to Book	0.30
Revenue Per Employee	$5,325.30

Feed

News

Sentiment

Earnings

Fundamentals

Info

CATX Fundamentals